A Study of E7386 in Combination With Other Anticancer Drug in Participants With Solid Tumor
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
The primary objective of this study is to assess the safety and tolerability and to determine the recommended Phase 2 dose (RP2D) of E7386 in combination with other anticancer drug(s).
创建时间：
2019-07-15
